XJPX
4189
Market cap684mUSD
Feb 24, Last price
3,035.00JPY
1D
1.61%
1Q
25.72%
Jan 2017
146.75%
IPO
139.92%
Name
KH Neochem Co Ltd
Chart & Performance
P/E
12.76
P/S
0.89
EPS
237.84
Div Yield, %
3.46%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
4.92%
Revenues
119.76b
+3.94%
Net income
8.36b
+22.47%
CFO
6.98b
-47.11%
Dividend
Jun 29, 202655 JPY/sh
Earnings
May 06, 2026
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
KH Neochem Co., Ltd. researches, manufactures, and sells petrochemical products in Japan and internationally. It offers a range of chemical products, such as alcohols, esters, ketones, glycol ethers, synthetic fatty acids, aldehydes, diols, hydrocarbons, and functional monomers. The company provides basic chemicals, including butyl alcohol and acetate, 2-ethyl hexyl alcohol, and isononyl alcohol for use in paints, inks, thinners, detergents, plasticizer raw materials, and resin raw materials. It also offers performance materials, such as 2-ethyl hexanoic and isononanoic acid, diacetone acrylamide, and 1,3-butylene glycol for use in lubricants, water-borne paints, and cosmetics. In addition, the company provides electronic materials comprising propylene glycol monomethyl ether acetateP, and propylene glycol monomethyl ether-P for LCD panels and semiconductors. KH Neochem Co., Ltd. was founded in 1966 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||